Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statements of Cash Flows

v2.4.0.8
Consolidated Statements of Cash Flows (USD $)
 9 Months Ended
Sep. 30, 2014
Sep. 30, 2013
Business Acquisition, Purchase Price Allocation, Current Assets, Inventory, Total $ 0  
Payments of assets 0  
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Assets 0  
Business Acquisition, Goodwill, Expected Tax Deductible Amount 0  
CASH FLOWS FROM OPERATING ACTIVITIES:    
Net loss attributable to Tecogen Inc. (3,839,233) (3,616,179)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization 250,655 194,260
Change in provision for allowance on accounts receivable 18,000 (34,700)
Stock-based compensation 120,972 (8,105)
Changes in operating assets and liabilities    
Accounts receivable (796,659) 433,931
Unbilled revenue 521,327 (140,081)
Inventory, net (1,563,642) (961,185)
Due from related party (125,069) 55,837
Prepaid expenses and other current assets 1,756 (127,673)
Increase (Decrease) in Other Operating Assets 19,100 (33,000)
Increase (decrease) in:    
Accounts payable 747,810 1,746,631
Accrued expenses (149,470) 283,355
Due to related party 1,315,434 270,954
Deferred revenue (119,667) 396,328
Interest payable, related party (198,450) 72,553
Net cash used in operating activities (3,797,136) (1,467,074)
CASH FLOWS FROM INVESTING ACTIVITIES:    
Purchases of property and equipment (148,833) (163,824)
Disposal of property and equipment 7,569 0
Purchases of intangible assets (130,905) (332,862)
Cash paid for asset acquisition 0 497,800
Purchases of short-term investments, restricted (585,038) (202)
Maturities of short-term investments, restricted 0 182,061
Net cash used in investing activities (857,207) (812,627)
CASH FLOWS FROM FINANCING ACTIVITIES:    
Payments for debt issuance costs (9,668) 0
Proceeds (payments) on demand notes payable and line of credit to related party 2,950,000 (1,200,000)
Proceeds from the exercise of stock options 2,340,194 0
Purchase of unvested restricted stock 6,000 0
Purchase of unvested restricted stock 0 350
Net cash (used in) provided by financing activities (613,474) 1,199,650
Net decrease in cash and cash equivalents (5,267,817) (1,080,051)
Cash and cash equivalents, beginning of the period 7,713,899 1,572,785
Cash and cash equivalents, end of the period 2,446,082 492,734
Non-cash investing and financing activities:    
Interest paid $ 294,219 $ 7,235